Cleft lip–Cone Rod Dystrophy Syndrome

Cleft lip–cone rod dystrophy syndrome is an extremely rare inherited condition in which a baby is born with a cleft lip, and later in life develops a progressive eye disease called cone-rod dystrophy that slowly damages the light-sensing cells (cones and rods) in the retina. In the medical literature it is usually described as a special form of “cleft lip-retinopathy syndrome”, where cleft lip is combined with a progressive retinopathy (disease of the retina).

Cleft lip-cone rod dystrophy syndrome is an extremely rare genetic condition where a baby is born with a cleft lip and later develops a slowly worsening disease of the light-sensitive cells (cones and rods) in the retina of the eye.[1] The cleft lip is a split or gap in the upper lip that happens early in pregnancy, and the cone-rod dystrophy causes progressive loss of central vision, colour vision and then side (peripheral) vision over time.[2] Because so few people in the world have been reported, almost all knowledge about treatment is taken from general cleft lip care and from research on cone-rod dystrophy and other inherited retinal dystrophies, rather than from large studies in this exact syndrome.[1][2]

This syndrome is also called cleft lip-retinopathy syndrome, cleft lip-progressive retinopathy syndrome or Ausems-Wittebol Post-Hennekam syndrome.[1] The main problems are feeding and speech difficulties in early life because of the cleft lip (and sometimes cleft palate), and progressive visual disability because the cones and rods in the retina slowly stop working.[1][2] Children usually start life with near-normal vision, then develop light sensitivity, problems seeing colours, blurred central vision and later difficulty seeing in dim light.[2][3]

The syndrome has been reported in only a few families, including a group of siblings from a consanguineous (related) marriage, which suggests that the condition is inherited in an autosomal recessive way: both parents carry one silent copy of a changed gene and together can pass on two changed copies to a child. The main visible features are a non-midline cleft of the upper lip and progressive cone-rod dystrophy that causes worsening vision, abnormal retinal pigmentation and retinopathy.

Because cone-rod dystrophy is a genetic retinal disorder, children with this syndrome usually have normal eyes at birth, but later develop problems with central vision, color vision, light sensitivity, and finally peripheral vision. Over time, both the cleft lip and the eye disease can affect appearance, feeding and speech (from the lip problem), and the child’s ability to see and learn (from the retinal problem).

Another names

Doctors may use several other names for the same syndrome. These names come from different research groups, older case reports, or from rare-disease databases:

1. Cleft lip-retinopathy syndrome

2. Cleft lip-progressive retinopathy syndrome

3. Cleft lip–cone-rod dystrophy syndrome

4. Cleft lip-progressive retinal dystrophy syndrome (descriptive term)

5. Ausems-Wittebol-Post-Hennekam syndrome (named after the first authors)

6. Ausems Wittebol-Post Hennekam syndrome (spelling variant)

All these names describe the same key idea: a child with a cleft lip and a slowly worsening retinal disease, usually in an autosomal recessive pattern and with very few cases worldwide.

Types

Because cleft lip–cone rod dystrophy syndrome is extremely rare and only a small number of families have been reported, there is no official, strict medical classification into many “subtypes”. However, for clinical understanding doctors may group patients into practical “types” based on how the lip and eye problems look and how fast vision gets worse.

1. Type 1 – Non-midline unilateral cleft lip with early-onset cone-rod dystrophy
   In this pattern, the cleft affects one side of the upper lip (non-midline), and retinal problems such as reduced central vision and color vision often begin in early childhood. This pattern is close to the original case description in the medical literature.

2. Type 2 – Non-midline cleft lip with later-onset cone-rod dystrophy
   Some individuals may have a visible cleft lip from birth but do not show clear eye symptoms until school age or adolescence, when reading difficulties, light sensitivity, or problems with night vision start. The retinal disease is the same, but the age at which symptoms are noticed is later.

3. Type 3 – Cleft lip with milder retinal involvement
   In a few patients, retinal changes may be present on eye examination and electroretinography, but vision problems are milder and progress more slowly, so the child may keep useful vision for many years. This reflects the general variability seen in cone-rod dystrophies.

4. Type 4 – Cleft lip with severe, rapidly progressive cone-rod dystrophy
   In this pattern, vision loss progresses quickly: central vision, color vision, and peripheral vision may all decline over childhood or adolescence, and the child may be legally blind in young adulthood. This mirrors the severe end of the cone-rod dystrophy spectrum.

5. Type 5 – Cleft lip–retinopathy with extra eye findings
   Some reports describe additional retinal signs such as peripheral pigment changes, macular lesions, or other retinopathy patterns. In these cases, the syndrome still has the cleft lip and progressive retinal disease, but with extra visible changes on fundus exam and imaging.

These “types” are descriptive and based on how patients look and progress; they do not represent officially separate diseases at this time.

Causes

Cleft lip–cone rod dystrophy syndrome appears to be mainly caused by inherited genetic changes, but only a few families are known, and the exact gene has not yet been clearly identified. Most of the detailed cause information comes from research on cone-rod dystrophy in general and on risk factors for cleft lip, not specifically from this tiny group of patients, so many “causes” below are general risk or contributing factors rather than proven specific causes for this named syndrome.

1. Autosomal recessive inheritance – The original family with cleft lip and cone-rod dystrophy came from a consanguineous marriage, and several siblings were affected, which strongly suggests autosomal recessive inheritance (two altered gene copies, one from each parent).

2. Pathogenic variants in cone-rod dystrophy genes (general) – More than 30 genes can cause cone-rod dystrophy (for example ABCA4, CRX, GUCY2D), and changes in one of these genes in a particular family could produce the retinal disease part of the syndrome, even though the exact gene for this syndrome is still unknown.

3. Mutations affecting retinal photoreceptor function – Many cone-rod dystrophy genes code for proteins that help cones and rods respond to light or maintain their structure. Harmful changes in these genes weaken the photoreceptors so they slowly die, causing progressive retinopathy.

4. Genetic variants involved in craniofacial development – Cleft lip can be caused by changes in genes that control face and lip formation in early pregnancy, such as BMP4 and other craniofacial genes, and a combination of such genes with retinal genes may explain this rare syndrome.

5. Consanguinity (parents being related) – When parents are related, they are more likely to carry the same rare recessive gene change. This increases the chance that a child will inherit two copies of that change and express the syndrome, as seen in the reported consanguineous sibship.

6. Family history of retinal dystrophy – In some families, cone-rod dystrophy or other inherited retinal diseases occur across generations. If a child with such a family background is also born with a cleft lip, it may represent this combined syndrome rather than two separate problems by chance.

7. Family history of cleft lip or cleft palate – Cleft lip and palate often show familial clustering, with higher risk in relatives of affected individuals, reflecting shared genetic susceptibility that might also play a role in the rare syndrome.

8. New (de novo) gene mutations – Sometimes a disease-causing mutation appears for the first time in a child, not present in either parent. De novo mutations are known in many retinal dystrophies and might also rarely contribute to a case that also has cleft lip.

9. Maternal smoking during early pregnancy (cleft risk) – Large studies show that mothers who smoke in early pregnancy have a higher risk of having babies with cleft lip and palate, so maternal smoking is an important environmental risk factor, though not a direct cause of the eye disease.

10. Maternal alcohol use (cleft risk) – Alcohol exposure in early pregnancy has been linked with facial malformations, including orofacial clefts, and may contribute to the cleft part of the syndrome in genetically vulnerable fetuses.

11. Poorly controlled maternal diabetes – Pre-existing or gestational diabetes in the mother is associated with a higher risk of birth defects, including cleft lip and palate, so maternal diabetes may be one of several environmental risk factors.

12. Folic acid deficiency and other vitamin B deficiencies – Low folic acid and deficiencies in vitamins B6, B9, and B12 in early pregnancy have been associated with higher risk of orofacial clefts, which may act together with genetic factors to produce cleft lip in this syndrome.

13. Teratogenic medications in early pregnancy – Some drugs taken in early pregnancy, such as certain anticonvulsants, corticosteroids, and vasoactive drugs, have been linked in reviews with increased risk of cleft lip and palate, and could contribute as environmental triggers.

14. Exposure to environmental toxins (for example pesticides) – Exposure to chemicals and pollutants has been discussed as a possible risk factor for clefts in some studies, although evidence is not as strong as for smoking or vitamin deficiency.

15. Advanced maternal age and other maternal factors – Higher maternal age, obesity, and some health conditions show associations with cleft formation, probably by interacting with genetic susceptibility rather than acting as single direct causes.

16. Maternal infections in early pregnancy – Certain infections during critical weeks of facial development are suspected risk factors for birth defects including clefts, although specific links to this rare syndrome have not been proved.

17. Environmental factors that promote DNA damage (for cone-rod dystrophy genes) – General information on cone-rod dystrophy notes that although most cases are inherited, mutations may also arise due to random errors or environmental factors such as radiation, which can damage DNA in retinal cells.

18. Multifactorial inheritance (genes plus environment) – For cleft lip and palate, most experts now accept a multifactorial model, where several genes plus environmental influences act together; the same complex model may underlie this combined cleft-retinopathy syndrome.

19. Unknown or yet-unknown genes specific to this syndrome – It is possible that a single, as-yet-undiscovered gene explains the combination of cleft lip and retinal dystrophy in the reported families; this is suspected because of the consistent pattern in siblings.

20. Chance association in some isolated cases – The original authors also noted that in theory the association could be due to chance in some individuals, because cleft lip and retinal dystrophies are each relatively common rare conditions; however, the pattern in a consanguineous family makes a shared cause more likely.

Symptoms

Symptoms in cleft lip–cone rod dystrophy syndrome combine problems from the cleft lip and from the cone-rod dystrophy of the retina. The exact mix and timing of symptoms can differ widely between individuals, even in the same family.

1. Visible cleft of the upper lip – A baby is born with a split or gap in the upper lip, often off the midline, which is usually obvious on physical examination and may affect feeding and early bonding if not repaired.

2. Difficulty feeding in infancy – The cleft lip can make it harder for the baby to form a tight seal around the breast or bottle, leading to poor suction, choking, or long feeding times, and sometimes poor weight gain.

3. Nasal speech and articulation problems – As the child grows, the cleft lip (and any minor palate involvement) can affect speech, leading to nasal tone or unclear pronunciation that usually needs speech therapy after surgery.

4. Recurrent ear and upper airway problems – Children with cleft conditions may have eustachian tube dysfunction and middle-ear fluid, causing frequent ear infections and temporary hearing issues, which can further affect speech development.

5. Reduced central visual acuity – One of the earliest eye symptoms is blurred central vision, making it hard to read small print, see faces clearly, or manage school tasks; this is typical for cone-rod dystrophy.

6. Loss of color vision – Damage to cone cells causes difficulty distinguishing colors, especially red and green or blue and yellow, so objects may look faded or “wrong” in color.

7. Photophobia (sensitivity to bright light) – Many affected individuals feel discomfort or pain in bright sunlight or strong indoor lighting and may squint, close one eye, or prefer dim environments.

8. Central scotoma (central blind spot) – Over time, some people develop a dark or blurry area in the center of their field of vision, making reading and recognising faces particularly difficult.

9. Night blindness (nyctalopia) – As rod cells become involved, seeing in low light or at night becomes difficult, so the person may stumble in dim rooms, have trouble going out after dark, or take longer to adapt when lights are turned off.

10. Peripheral visual field loss – With progression, the outer parts of the visual field can shrink, leading to “tunnel vision” where only straight-ahead objects are seen clearly, and side obstacles are missed.

11. Abnormal retinal pigmentation – Eye doctors often see speckled or mottled pigment changes in the retina, especially in the peripheral areas, reflecting ongoing photoreceptor damage.

12. Nystagmus or abnormal eye movements – Some patients may develop involuntary, small, jerky eye movements as the brain tries to improve poor vision by constantly adjusting eye position.

13. Abnormal head posture and squinting – To see better, a child may tilt the head, turn to one side, or narrow the eyelids, especially in bright light or when trying to focus on small objects.

14. Psychological and social impact – Facial difference from the cleft lip and progressive visual loss can cause self-consciousness, anxiety, or sadness, and children may face bullying or feel excluded without good psychological and family support.

15. Learning difficulties related to vision, not intellect – Most descriptions of this syndrome do not highlight intellectual disability; instead, school problems usually arise from poor vision (trouble reading, seeing the board) and communication challenges, which can often be improved with early educational support and visual aids.

Diagnostic tests

Diagnosis of cleft lip–cone rod dystrophy syndrome is based on the combination of physical examination (cleft lip), detailed eye evaluation, retinal function tests, and genetic investigations to look for inherited retinal dystrophy and possible causative genes.

1. Comprehensive physical and dysmorphology examination – A clinical geneticist or pediatrician examines the face, mouth, body proportions, and any other physical differences to confirm the cleft lip, look for midline or non-midline location, and check for other anomalies that might suggest a broader syndrome.

2. Growth and nutritional assessment – Height, weight, and head circumference are tracked to see whether feeding problems from the cleft lip or visual disability are affecting growth, and to rule out other systemic syndromes.

3. Detailed ophthalmic external examination – An ophthalmologist looks at the eyelids, cornea, lens, pupils, and eye movements to detect nystagmus, strabismus (eye misalignment), or other signs that might accompany retinal disease.

4. Visual acuity testing (manual eye-chart testing) – Using age-appropriate charts (pictures, letters, or symbols), the examiner measures how clearly each eye can see, which shows the impact of cone-rod dystrophy on central vision.

5. Color vision testing (for example Ishihara plates) – Special color dot or plate tests are used to check how well the patient can distinguish colors; early loss of color vision is typical in cone-rod dystrophy and supports the diagnosis.

6. Visual field testing (manual confrontation and automated perimetry) – At first, simple bedside confrontation tests compare the patient’s peripheral vision with the examiner’s; later, automated perimetry machines map detailed visual field loss, including central scotomas and tunnel vision.

7. Refraction and retinoscopy (manual lens testing) – The eye care professional checks whether glasses or contact lenses can improve vision and distinguishes between vision loss from refractive error and that from retinal degeneration.

8. Slit-lamp biomicroscopy – A slit-lamp microscope allows close examination of the front part of the eye (cornea, lens, anterior chamber) to rule out other eye diseases and to check for any associated changes that might appear in syndromic retinal dystrophies.

9. Fundus examination (indirect ophthalmoscopy) – The doctor uses special lenses and lights to look at the retina, macula, and optic nerve at the back of the eye, observing pigment changes, retinal thinning, and other signs of cone-rod dystrophy.

10. Fundus photography – High-resolution photographs of the retina are taken to document the appearance of pigmentary changes and to follow the progression of retinal damage over time.

11. Optical coherence tomography (OCT) – OCT is a non-invasive imaging test that uses light waves to create cross-sectional images of the retina, showing thinning or loss of photoreceptor layers typical of cone-rod dystrophy.

12. Fundus autofluorescence imaging – This imaging technique shows patterns of lipofuscin (metabolic waste) in retinal pigment epithelial cells and can highlight areas of stressed or dying photoreceptors in cone-rod dystrophy.

13. Full-field electroretinography (ERG) – ERG measures the electrical response of rods and cones to light flashes; in cone-rod dystrophy, cone responses are reduced earlier and more severely than rod responses, which is a key diagnostic feature.

14. Pattern ERG / multifocal ERG – These specialised ERG tests focus on macular and central retinal function, detecting early cone dysfunction even before obvious fundus changes or severe visual acuity loss appear.

15. Visual evoked potentials (VEP) – VEP records electrical signals from the visual cortex in response to visual stimuli and helps assess the integrity of the whole visual pathway from retina to brain, excluding other neurological causes of vision loss.

16. Targeted retinal gene panels (NGS panel for cone-rod dystrophy) – Next-generation sequencing panels that include many cone-rod dystrophy genes (such as ABCA4, CRX, GUCY2D and others) can identify pathogenic variants, confirm the genetic cause of the retinal disease, and support syndromic diagnosis.

17. Broader genomic testing (exome or genome sequencing) – When targeted panels are negative, whole-exome or whole-genome sequencing may be used to search for previously unknown genes that could explain the combined cleft lip and retinal dystrophy pattern.

18. Laboratory tests for maternal and child risk factors – Blood tests for folate, vitamin B12, other B vitamins, and markers of diabetes in the mother (or sometimes in the child if metabolic concerns exist) help to explore environmental contributors to cleft formation and overall health, even though they do not directly diagnose the syndrome.

19. Brain and orbit MRI (if indicated) – Magnetic resonance imaging of the brain and orbits may be done if there are unusual neurological signs, to exclude other structural brain or optic nerve abnormalities that could mimic or add to visual problems.

20. Prenatal ultrasound for cleft detection – In many pregnancies, a significant cleft lip can be seen on second-trimester ultrasound, which may lead to early suspicion of a cleft-related condition; however, the retinal dystrophy part of the syndrome cannot be detected prenatally and appears later in life.

Non-pharmacological treatments

1. Early cleft lip repair (cheiloplasty)
   Surgical repair of the cleft lip in the first months of life helps the baby feed better, improves appearance and supports normal speech development later.[1] The surgeon carefully joins the separated lip tissues to create a more normal shape and function, often in a single operation.[1] This repair does not change the eye disease, but it is a vital non-drug treatment that improves nutrition, growth, social interaction and self-confidence, which are all important in a child who will later face visual disability.[1][2]

2. Feeding and swallowing therapy
   Babies with cleft lip (and cleft palate if present) often struggle to create suction, so they may not gain weight well.[1] Special feeding bottles, specific positions and guidance from a feeding or speech therapist can make it easier for the baby to drink safely and get enough calories.[1] Better nutrition supports brain and eye development and helps the child be strong enough for surgeries and future vision rehabilitation.[2]

3. Speech and language therapy
   Cleft lip and palate can cause nasal-sounding speech and articulation problems, even after surgery.[1] Regular speech and language therapy helps the child learn clear pronunciation, proper airflow and communication skills in simple, step-by-step exercises.[1] Good communication is especially important for children with progressive vision loss, because they will rely heavily on language for learning and social life.[2]

4. Low-vision rehabilitation
   Low-vision rehabilitation uses tools and training to make the best use of remaining sight when cone-rod dystrophy reduces vision.[2] This may include magnifiers, large-print materials, high-contrast reading lamps and training to hold books or screens at the best distance.[2] Low-vision specialists teach practical skills such as reading, writing and using computers with enlarged fonts so that the child or adult can continue school and daily life as independently as possible.[3]

5. Orientation and mobility training
   As peripheral vision and night vision worsen, moving safely becomes harder.[2] Orientation and mobility specialists teach skills such as using a white cane, detecting obstacles, planning safe routes, and using sound and touch cues in the environment.[3] Early training reduces the risk of falls and accidents and helps young people keep confidence in walking alone, going to school and later using public transport.[2]

6. Tinted lenses and glare control
   Cone-rod dystrophy often causes severe light sensitivity and glare.[2] Using tinted lenses, wrap-around sunglasses, brimmed hats and indoors lighting adjustments can reduce discomfort and improve vision quality.[2] Filters can be chosen by colour and strength based on specialist testing, so that the person can see as clearly as possible while still protecting the retina from bright light.[3]

7. Electronic visual aids and screen accessibility
   Tablets, phones and computers can be powerful tools when vision is reduced.[2] Screen readers, text-to-speech, high-contrast modes, zoom functions and large icons allow the user to read, write and browse with less eye strain.[3] Training in these settings and in using external devices such as electronic magnifiers can greatly expand educational and work possibilities for people with cleft lip-cone rod dystrophy syndrome.[3]

8. Educational support and special accommodations
   Children with progressive retinal dystrophy may need seating near the front of the classroom, printed materials in large font, audio books, extended exam time and digital formats.[2] Teachers and school counsellors should understand that vision may gradually worsen over years and adjust plans regularly.[3] With the right support, many students with cone-rod dystrophy can complete normal schooling and even higher education.[3]

9. Psychological counselling and family support
   Living with facial difference from cleft lip and the fear of losing sight can cause anxiety, sadness and social withdrawal.[1][2] Psychologists or counsellors familiar with chronic illness can help the child and family express feelings, build coping strategies and fight stigma.[2] Support groups, peer mentoring and contact with other families facing inherited retinal diseases also reduce isolation and improve mental well-being.[3]

10. Genetic counselling
    Because cone-rod dystrophy is usually genetic, families benefit from meeting a genetic counsellor who can explain possible inheritance patterns, recurrence risks and options for future pregnancies.[2] Counsellors can also arrange genetic testing panels for cone-rod dystrophy genes when available, which may help clarify the diagnosis and open access to research trials.[3] This information allows families to make informed reproductive decisions and to identify other relatives who may need eye checks.[2]

11. Regular ophthalmic monitoring
    Even without a cure, regular eye examinations with retinal imaging and electroretinography help track disease progression and pick up treatable complications like macular edema or cataract.[2][3] Early detection of complications allows timely use of supportive treatments, and updated visual function reports help in planning school, work and rehabilitation needs over time.[2]

12. Assistive technology for reading and communication
    Screen readers, braille displays, audio note-takers and smart-phone accessibility features can replace or support print reading as vision declines.[3] Training in these tools should start before vision is very poor so that the child or adult does not experience a sudden loss of independence when reading becomes difficult.[3] Many modern devices include these functions at no extra cost, making them easier to access worldwide.[2]

13. Occupational therapy for daily living skills
    Occupational therapists help people with low vision learn safe cooking, dressing, grooming and home organisation techniques using contrast, labelling and touch markers.[2] This training aims to keep the person as independent as possible in their own home, even when they cannot rely on detailed vision.[3] It also reduces caregiver stress and helps the family see what the person can still do with the right strategies.[2]

14. Social work and disability benefits support
    Social workers can explain local disability schemes, travel concessions, assistive device funding and inclusive education policies.[2] They may also help with workplace adaptations and anti-discrimination support when the person is older.[3] Access to these services can lower financial stress on families who must pay for repeated surgeries, eye visits and assistive technology.[2]

15. Good sleep, activity and mental-health habits
    Regular sleep, physical activity suited to the child’s abilities and simple relaxation techniques support brain function and mood, which indirectly help with coping with chronic vision loss.[2] Simple routines like daily walks with a caregiver, breathing exercises or mindfulness can reduce stress and help with concentration at school.[3] Although these measures do not change the disease process, they improve overall quality of life and resilience.[2]

16. Avoidance of eye trauma and harsh light
    People with cone-rod dystrophy may be more vulnerable to damage from trauma or strong light.[2] Wearing protective eyewear during sports, using UV-blocking sunglasses outside and avoiding looking directly at bright light sources can reduce additional harm to already fragile retinal cells.[3] These measures are simple, low-cost and safe and are usually recommended for all inherited retinal dystrophies.[2]

17. ENT and dental follow-up for cleft-related problems
    Cleft lip (and palate if present) can cause recurrent ear infections, hearing loss and dental malalignment.[1] Regular visits to ear, nose and throat (ENT) specialists and dentists help prevent or treat these issues through ear tubes, hearing aids, orthodontics and dental care.[1] Better hearing and oral health make communication and learning easier, especially when vision is poor and the child must rely more on hearing.[2]

18. Community-based rehabilitation in low-resource settings
    In areas with limited healthcare, community health workers and simple low-cost tools (handheld magnifiers, high-contrast materials, local support groups) can still improve outcomes.[2] Training family members and school teachers in basic low-vision strategies allows children with cleft lip-cone rod dystrophy syndrome to stay in local schools and participate in community life.[3] International guidelines for community-based rehabilitation stress inclusion, simple assistive devices and local advocacy for people with visual disabilities.[2]

19. Tele-health follow-up where available
    Tele-ophthalmology and tele-rehabilitation allow people who live far from major hospitals to receive specialist advice, monitor vision changes and adjust rehabilitation plans using video calls and remote tests.[2] This is especially useful for rare diseases, where experienced specialists may be located only in large centres.[3] It reduces travel cost and time while still providing access to expert care.[2]

20. Participation in patient registries and research studies
    Because cleft lip-cone rod dystrophy syndrome is so rare, joining rare-disease registries and research projects helps doctors learn more about it.[1][2] Registries may collect genetic, clinical and imaging data and can inform future treatment trials, including gene and cell therapy studies.[3][4] Participation is voluntary and should always follow clear informed-consent processes, but it can contribute to better care for future patients with this syndrome.[2]

Drug treatments and medicines

There are no FDA-approved medicines that specifically cure or stop cleft lip-cone rod dystrophy syndrome or cone-rod dystrophy at this time.[2][3] Most medicines used are supportive, treating complications such as inflammation, macular swelling or infection, or they are part of research programmes for inherited retinal dystrophy in general.[3][4] Any medicine must be prescribed only by an ophthalmologist or clinical geneticist after careful risk-benefit discussion, and doses should never be changed without medical supervision.[2]

Because you asked specifically about drugs with evidence from official sources such as FDA databases, here are examples of drug and biological therapies that are relevant to inherited retinal diseases, even though they are not approved specifically for cleft lip-cone rod dystrophy syndrome:

1. Voretigene neparvovec-rzyl (LUXTURNA) – gene therapy
   This is an adeno-associated virus (AAV) gene therapy approved by the FDA for patients with biallelic RPE65-mutation-associated retinal dystrophy.[1] It is injected under the retina in a surgical procedure and delivers a working copy of the RPE65 gene to retinal cells.[1] It shows how gene therapy can restore some vision in specific inherited retinal dystrophies, but it only applies to a defined genetic subgroup and is not yet available for the unknown genes in cleft lip-cone rod dystrophy syndrome.[1][2]

2. Investigational AAV gene therapies for cone-rod dystrophy
   Several early-phase clinical trials are testing subretinal AAV gene therapies (for example SPVN06 and other vectors) in rod-cone or cone-rod dystrophy.[2][3] These products aim to deliver protective genes or neurotrophic factors to photoreceptors to slow degeneration.[3] At present they are experimental, available only in trials, and their long-term benefits and risks are still being studied.[2][3]

3. Anti-VEGF intravitreal injections (ranibizumab, aflibercept and others)
   Drugs that block vascular endothelial growth factor (VEGF) are approved for many retinal vascular diseases and for macular degeneration.[4] In rare cases where cone-rod dystrophy is complicated by choroidal neovascular membranes or macular edema, retina specialists may use these injections off-label to treat the complication, not the underlying inherited dystrophy.[4] These injections are given into the eye at regular intervals and can reduce leakage and swelling, but they do not correct the genetic cause.[4]

4. Carbonic anhydrase inhibitors (oral acetazolamide, topical dorzolamide)
   These drugs are approved for glaucoma and systemic conditions, but retinal specialists sometimes use them off-label to reduce cystoid macular edema in inherited retinal dystrophies.[4] They work by changing fluid transport across retinal and choroidal tissues, which can shrink cystic spaces in some patients.[4] Response is variable and side effects like tingling, fatigue or kidney stone risk must be monitored.[4]

5. Corticosteroids (systemic or intraocular) for inflammatory complications
   Short courses of steroids may be used if secondary inflammation develops, for example after surgery or if there is uveitis.[4] Steroids reduce inflammatory signalling in ocular tissues and can relieve pain and swelling, but long-term use can raise eye pressure and cause cataract, so they are used cautiously.[4] They are not a routine treatment for pure cone-rod dystrophy.[3]

6. Lubricating eye drops and gels
   Preservative-free artificial tears and gels are approved as medical devices or over-the-counter products to relieve dry eye symptoms.[4] People with low vision may blink less or have more eye strain, so surface dryness is common, and lubrication can reduce discomfort and improve clarity.[4] These products are safe when used as directed but should not be seen as disease-modifying drugs.[2]

7. Antibiotic eye drops or ointments after surgery
   Short courses of topical antibiotics are used after cleft lip surgery (for wound care) or after ocular procedures to reduce infection risk.[1][4] These medicines kill or block bacteria at the surgical site but have no effect on the genetic eye disease itself.[1] They are usually used for a few days only under surgeon guidance.[1]

8. Analgesics (pain-relief medicines)
   Paracetamol (acetaminophen) and, when needed, short-term non-steroidal anti-inflammatory drugs (NSAIDs) may be used for post-operative pain or headaches related to eye strain.[4] Doses must be age-appropriate and must respect kidney, liver and stomach safety rules.[4] These medicines improve comfort but again do not treat cone-rod dystrophy directly.[2]

9. AREDS2-type antioxidant micronutrient formulas (off-label use)
   Special combinations of vitamins C and E, zinc, copper, lutein and zeaxanthin (AREDS2 formulas) are approved as supplements to slow progression of intermediate age-related macular degeneration.[5] Some clinicians consider similar antioxidant formulas for inherited retinal dystrophies, but evidence is weak, and any use is off-label and should follow eye-specialist advice.[5] Over-dosing can cause side effects, so medical supervision is essential.[5]

10. Supportive systemic medications
    Depending on associated conditions (for example seizures, developmental delay or other syndromic features if present), neurologists or paediatricians may prescribe additional medicines.[1] These drugs treat the extra features of the syndrome but should always be checked for possible eye or retinal side effects (some drugs are known to be toxic to the retina and should be avoided).[4] Careful medication review by the ophthalmologist and paediatrician together is important.[2]

Because your request was for 20 drugs, it is important to be very clear: beyond the examples above, there is no strong evidence from accessdata.fda.gov for other medicines that specifically treat cleft lip-cone rod dystrophy syndrome itself, so adding long lists of “disease-specific drugs” would be misleading and unsafe.[1][2] Any medicine must be individualised by the treating specialists.

Dietary molecular supplements

Dietary supplements for this syndrome are supportive. They may help overall eye and body health but do not cure cone-rod dystrophy. Doses should follow product labels and doctor advice, because very high doses can be harmful.[3][4]

1. Lutein – A carotenoid concentrated in the macula; it may help filter blue light and reduce oxidative stress in retinal cells.[4] Typical supplement doses are around 10 mg per day in AREDS2 formulas, but the right dose for a child or for inherited retinal dystrophy is not clearly established.[4]

2. Zeaxanthin – Another macular carotenoid that works with lutein to protect central retina from light-induced damage.[4] AREDS2-type products often contain about 2 mg daily, sometimes combined with lutein and omega-3 fatty acids.[4]

3. Omega-3 long-chain fatty acids (DHA/EPA)
   Omega-3 fats are key components of photoreceptor cell membranes and may support retinal function.[4] Supplements are often in the range used for general eye health in adults, but specific evidence for cone-rod dystrophy is limited, so dosing must follow physician advice.[4]

4. Vitamin A (within safe limits)
   Vitamin A is essential for the visual cycle and rod function, but high doses can be toxic, especially in young children or pregnancy.[4] Some inherited retinal dystrophy protocols in other diseases have tested moderate vitamin A doses, but this must never be self-started and always checked with genetics and liver function.[4]

5. Vitamin C
   Vitamin C is a water-soluble antioxidant found in fruits and vegetables and in AREDS2 supplements at 500 mg per day for adults with AMD.[5] It helps neutralise free radicals in ocular tissues, but again the exact benefit in cone-rod dystrophy is uncertain, so balanced diet is preferred and supplements only with medical supervision.[5]

6. Vitamin E
   Vitamin E stabilises cell membranes and reduces oxidative damage; AREDS-type formulas use about 400 IU daily in adults with AMD.[5] Inherited retinal dystrophy patients may receive similar antioxidant support in some clinics, but high-dose vitamin E can interact with blood-thinning medicines and must be used cautiously.[4][5]

7. Zinc with copper
   Zinc is important for retinal enzyme function, but high doses can cause copper deficiency, so AREDS2 formulas include both.[5] Supplements should never exceed recommended doses without medical review, especially in children with low body weight.[5]

8. B-complex vitamins (B2, B6, B12, folate)
   B-vitamins support nerve health and energy metabolism. While there is no proof they slow cone-rod dystrophy, correcting deficiencies is important for general neurological function and may help with fatigue and mood.[4] A multivitamin at age-appropriate dose is usually safer than high-dose single B-vitamins.[4]

9. Vitamin D
   Vitamin D supports immune regulation and bone health and may also have indirect neuroprotective effects.[4] Many people have low vitamin D, so correcting deficiency through safe sun exposure, diet or supplements may be useful, but blood levels should be monitored to avoid overdose.[4]

10. Probiotic and prebiotic supplements
    The gut microbiome may influence inflammation and absorption of nutrients like lutein and omega-3 fats.[4] Probiotic or fibre-rich supplements may support general health and possibly help nutrient absorption, but evidence in inherited retinal dystrophy is still very early, so they should be seen as general wellness support rather than eye treatment.[4]

Immune-supporting, regenerative and stem-cell-based approaches

In your request you asked for “immunity booster, regenerative and stem-cell drugs”. For this syndrome, there are no approved stem-cell drugs or immune-boosting medicines that are proven to stop cone-rod dystrophy.[3][4] Below are research directions and supportive approaches, not standard cures.

1. Gene therapy for inherited retinal dystrophy
   Gene therapy uses viral vectors (like AAV) to deliver a healthy copy of a gene to retinal cells.[3] The best known example is voretigene neparvovec for RPE65-related dystrophy, and several other gene therapies are in trials for rod-cone and cone-rod dystrophies, aiming to protect or restore photoreceptors.[2][3] None are yet targeted specifically to cleft lip-cone rod dystrophy syndrome, but future genetic discoveries may open that possibility.[3]

2. Stem-cell-derived retinal pigment epithelium (RPE) transplantation
   Clinical trials are testing transplantation of stem-cell-derived RPE cells under the retina in diseases such as age-related macular degeneration and Stargardt disease.[3][4] The aim is to support surviving photoreceptors and possibly improve or stabilise vision.[4] So far, early trials show some safety and modest visual gains but long-term outcomes and risks like retinal detachment are still being studied, and these therapies are not routine for cone-rod dystrophy.[3][4]

3. Photoreceptor progenitor cell transplantation
   Another regenerative approach is to transplant stem-cell-derived photoreceptor precursors that may integrate into the retina and replace lost cones and rods.[3] Preclinical and early clinical work suggests this might partially restore light responses, but many challenges remain, including cell survival, integration and immune rejection.[3][4] At present this is strictly experimental and available only in carefully controlled research trials.[3]

4. Neuroprotective and trophic factor therapies
   Some gene therapies and biologics in testing for rod-cone dystrophy deliver neurotrophic factors or modulators of cell death pathways instead of replacing a gene.[2] These agents aim to “boost” the survival of retinal cells and may be considered a regenerative-supportive strategy if proven effective.[2][3] At present they are still in early-phase trials and not approved for general use.[2]

5. General immune health support (vaccinations and infection control)
   While no immune-boosting drug is proven to help cone-rod dystrophy, keeping the immune system healthy with routine vaccinations, good nutrition, sleep and physical activity is important.[4] These measures reduce the risk of systemic infections that might complicate surgeries or overall health, helping the person stay fit for any future regenerative therapy trials.[4]

6. Participation in regulated clinical trials only
   Because stem-cell “treatments” offered outside regulated trials have sometimes caused serious eye damage, expert groups strongly advise patients with inherited retinal diseases to avoid unproven commercial stem-cell clinics.[3][4] Instead, any regenerative therapy should be accessed only through official university or hospital-based studies that have ethics approval and long-term safety monitoring.[3][4]

Surgeries related to cleft lip-cone rod dystrophy syndrome

1. Primary cleft lip repair (cheiloplasty) – closes the lip gap, improves feeding and appearance and is usually done in the first months of life.[1]

2. Cleft palate repair (palatoplasty) – if the palate is involved, surgery closes the gap in the roof of the mouth to improve speech, swallowing and ear function.[1]

3. Secondary speech and palate surgeries – later procedures may correct velopharyngeal insufficiency (air escaping through the nose) to improve speech clarity.[1]

4. Alveolar bone grafting and orthodontic surgery – bone grafts to the upper jaw and orthodontic or orthognathic surgery help align teeth and jaws, improving chewing and facial symmetry.[1]

5. Ocular surgeries for complications (cataract extraction, retinal procedures) – some patients with inherited retinal dystrophy develop cataract or other treatable eye problems; surgery can improve the amount of usable vision even if it cannot cure the retinal degeneration.[2][3]

Prevention and risk reduction

Cleft lip-cone rod dystrophy syndrome is genetic, so it cannot be fully prevented, but some steps may reduce general risk or help with early detection:

1. Pre-conception and antenatal folic acid supplementation as advised for all pregnancies may reduce the risk of some facial clefts.[1]

2. Avoiding smoking, alcohol and recreational drugs during pregnancy reduces risk of many birth defects and growth problems.[1]

3. Avoiding known teratogenic medications in pregnancy where possible and using safer alternatives under medical guidance.[1]

4. Seeking genetic counselling if there is a family history of cleft lip, cone-rod dystrophy or other rare syndromes.[2]

5. Ensuring good control of maternal illnesses (e.g., diabetes) during pregnancy to lower general malformation risk.[1]

6. Attending regular antenatal visits and ultrasound scans so that cleft lip can be detected early and birth planning arranged.[1]

7. Keeping vaccinations up to date to avoid infections that could complicate pregnancy or early infancy.[4]

8. Avoiding unnecessary radiation exposure during pregnancy where possible.[1]

9. After birth, ensuring regular eye examinations for any sibling with possible visual symptoms or genetic risk.[2]

10. Educating the family about early signs of visual difficulty (light sensitivity, colour problems, clumsiness) so that children get prompt eye referrals.[2]

When to see doctors

People with suspected or confirmed cleft lip-cone rod dystrophy syndrome should see:

• A paediatrician and cleft team soon after birth for feeding, growth and surgical planning.[1]

• A paediatric ophthalmologist or inherited retinal disease specialist as soon as there are signs of visual problems such as light sensitivity, colour difficulty, reading trouble, bumping into objects or night blindness.[2][3]

• A geneticist or genetic counsellor if there is a family history of similar problems or for advice about future pregnancies.[2][3]

• An eye doctor urgently if there is sudden vision loss, eye pain, redness, flashes, floaters, severe headaches or trauma, because these may indicate treatable complications such as retinal detachment or infection.[2][3]

Regular follow-up schedules are usually individual, but many specialists recommend annual or more frequent eye checks in childhood and whenever symptoms change.

---

What to eat and what to avoid

1. Eat plenty of leafy green vegetables such as spinach, kale and collard greens, which are rich in lutein and zeaxanthin that support macular health.[4]

2. Include oily fish (such as salmon, mackerel or sardines) one to two times per week, providing omega-3 fatty acids that are important for retinal cell membranes.[4]

3. Add colourful fruits and vegetables like carrots, sweet potatoes, peppers, oranges and berries, which supply beta-carotene and vitamin C to help protect eye tissues from oxidative stress.[4]

4. Use nuts and seeds in moderation (almonds, sunflower seeds, flaxseed, chia) to provide vitamin E and healthy fats that may support eye and nerve health.[4]

5. Choose whole grains and legumes instead of refined carbohydrates to stabilise blood sugar and support overall vascular and retinal health.[4]

6. Stay well hydrated with water across the day to help prevent dry eyes and support general health.[4]

7. Limit highly processed foods, sugary drinks and very salty snacks, as they add calories without helpful nutrients and may worsen long-term vascular risk.[4]

8. Avoid smoking and second-hand smoke, which are strongly linked to faster progression of many retinal and macular diseases.[4]

9. Limit excessive alcohol intake, which can harm the nervous system and overall eye health.[4]

10. Use supplements only when recommended by your doctor, because high doses of vitamins or minerals can have side effects or interact with medicines, and evidence in cone-rod dystrophy is limited.[4]

---

Frequently asked questions

1. Is cleft lip-cone rod dystrophy syndrome the same as typical cleft lip?
   No. Typical cleft lip involves only the lip (and sometimes palate), while cleft lip-cone rod dystrophy syndrome also includes a progressive inherited retinal disease that causes vision loss over time.[1][2]

2. Can surgery cure the eye problem in this syndrome?
   Surgery can repair the cleft lip and palate and treat complications like cataract, but it cannot fix the underlying genetic cone-rod dystrophy in the retina.[2][3] Retinal degeneration needs different approaches such as low-vision rehabilitation and, in future, gene or cell therapies.[3]

3. Will every child with this syndrome go blind?
   Cone-rod dystrophy usually causes significant visual impairment, but the exact speed and final level of vision differ between individuals.[2][3] Some people keep useful vision for reading or mobility into adulthood, especially with good lighting and aids, while others have more severe loss.[2]

4. At what age does vision usually start to decline?
   Many children start with near-normal vision and develop symptoms in school-age years or adolescence, such as difficulty reading, seeing colours or seeing in bright light.[2][3] Over time peripheral and night vision may also worsen.[2]

5. Is there any proven medicine that stops cone-rod dystrophy now?
   At present there is no medicine or supplement that has been proven in large human trials to stop or reverse cone-rod dystrophy.[2][3] Management focuses on protection, rehabilitation and research participation when appropriate.[3]

6. Why do doctors talk about gene therapy if it is not available for this syndrome yet?
   Gene therapy has already worked for one inherited retinal dystrophy (RPE65-related disease), so researchers are hopeful that similar methods can be developed for other genes.[3][4] However, for cleft lip-cone rod dystrophy syndrome the responsible gene is not clearly known, so gene therapy remains a future hope rather than a current treatment.[3]

7. Are stem-cell injections offered in private clinics safe for this condition?
   Many unregulated stem-cell clinics around the world offer expensive treatments without strong evidence and have sometimes caused serious harm, including blindness.[3][4] Experts recommend that patients with inherited retinal dystrophy access stem-cell therapy only through properly regulated clinical trials at recognised centres.[3]

8. Can diet alone stop my vision from getting worse?
   No diet can cure the genetic problem, but a balanced diet rich in leafy greens, fruits, fish and whole grains supports overall eye and body health.[4] Supplements such as AREDS2 formulas have proven benefit in age-related macular degeneration, but their effect in cone-rod dystrophy is uncertain and must be discussed with an eye specialist.[4][5]

9. Will my child be able to attend regular school?
   With early cleft repair, appropriate speech therapy and strong low-vision support (large print, audio, technology, mobility training), many children can attend mainstream school successfully.[2][3] Early communication with teachers and regular re-assessment of needs are vital.[3]

10. Should brothers and sisters also have eye examinations?
    Yes, siblings should have eye checks if there is any visual symptom or if a genetic cause is suspected, because some inherited retinal diseases may affect more than one family member.[2][3] Genetic counselling can help decide who needs testing.[3]

11. Is it safe for a person with this syndrome to play sports?
    Many people can play non-contact sports safely with proper eye protection and mobility training, but choices should be adjusted as vision declines.[2][3] Contact or high-impact sports may carry higher risk of eye injury and should be discussed with the eye doctor.[3]

12. Can this syndrome affect hearing or other organs?
    Cleft lip alone mainly affects the face and mouth, but if a cleft palate is present there can be ear and hearing problems; cone-rod dystrophy primarily affects the eyes.[1][2] Some rare syndromic cases may include other features, so full medical assessment is important.[1][2]

13. What is the long-term outlook for someone with cleft lip-cone rod dystrophy syndrome?
    Most people will live a normal lifespan but with significant visual disability and a history of facial surgery.[1][2] With coordinated care (cleft team, eye specialists, rehabilitation, psychological support), many can study, work and live independently, using assistive technology and orientation skills.[2][3]

14. Can I find other families with this same syndrome?
    Because this condition is extremely rare, it may be hard to find local families, but rare disease networks, inherited retinal disease foundations and online support groups may connect people with similar issues such as cone-rod dystrophy or syndromic clefting.[1][2] Clinicians can also link patients to registries and research studies.[3]

15. What is the most important thing I can do right now?
    The most important steps are to build a strong care team (cleft surgeons, ophthalmologists, geneticists, rehabilitation specialists), attend regular follow-ups, protect the eyes from injury and bright light, support mental health, and encourage independence with suitable aids.[2][3] Staying informed about research and considering safe participation in registries or trials can also contribute to future advances.[3]

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: January 29, 2025.